genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Teva
Cancer
OncoGenex Regains Custirsen Rights, as Teva Collaboration Ends
Drug Discovery
Teva Buys Labrys, Growing Pain Franchise in Up to $825M Deal
A-Lists
Biosimilars: 11 Drugs to Watch
News
Cipla Denies Report of Teva $6B Acquisition Offer
News
Endo Buys Somar, with Latin American Growth in Mind
Insights
JobWatch: Massachusetts Reveals 2020 Vision
News
Teva Launches $21M U.K. Collaboration on Trials, Dementia Research
A-Lists
Top 10 Job-Cutting Companies of 2013
News
Ranbaxy, Teva Settle Claims with NY Attorney General
Industry News
Teva Outbids Endo, Acquires NuPathe for $144M+
1
...
3
4
5
...
11
Page 4 of 11
Scroll Up
Scroll Up
